Go Pro
→ This AI fund sends investors payouts every Thursday (From Investors Alley) (Ad)tc pixel
LON:4BB

4basebio Final Earnings Report

4basebio logo
GBX 519.75 -5.25 (-1.00%)
As of 07/31/2026 07:54 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 0.94
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Final
Date
5/27/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4basebio Plc - Grant of Options & Director/PDMR Dealing
July 22, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-grant-options-director-060000215.html
4basebio awards new management share options to support long-term growth
July 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-awards-new-management-share-options-to-support-long-term-growth?utm_source=marketbeat.com&utm_medium=referral
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
August 2 at 1:00 AM  |  Stansberry Research (Ad)
4basebio Plc - Director Appointment
July 8, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-director-appointment-060000656.html
4basebio strengthens board with deep tech investor Cornel Chiriac
July 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-strengthens-board-with-deep-tech-investor-cornel-chiriac?utm_source=marketbeat.com&utm_medium=referral
4basebio Plc - Result of AGM & Issue of Options
July 2, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-result-agm-issue-163700429.html
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile
Earnings Tools